U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT07551089) titled 'Kinematic vs Mechanical Alignment in High Tibial Osteotomy' on April 19. Brief Summary: T... Read More
U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT07549217) titled 'Kinesiophobia, Fear of Falling, Functional Independence, and Psychological Status in Spina... Read More
U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT07549360) titled 'Leveraging Optimal Tolerance in Undernourished Infants to Support Growth' on April 18. Br... Read More
Tokyo, April 25 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061339) titled 'Pathological complete response and major pathological response as surrogat... Read More
Tokyo, April 26 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061374) titled 'Feasibility Study of a Self-Help Psychoeducational Program for Working Adu... Read More
Geneva, May 4 -- International Clinical Trials Registry received information related to the study (RBR-10rr2p5d) titled 'Laser therapy for Pain in individuals with Knee osteoarthrosis' on April 25. S... Read More
Geneva, May 4 -- International Clinical Trials Registry received information related to the study (RBR-5jbrjcb) titled 'Use of virtual nursing rounds at night to prevent falls in hospitalized older pa... Read More
Singapore, April 24 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combi... Read More
Singapore, April 24 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the p... Read More
Singapore, April 24 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-98650... Read More